Lindbrook Capital LLC Has $34,000 Stake in Teleflex Incorporated (NYSE:TFX)

Lindbrook Capital LLC lifted its position in Teleflex Incorporated (NYSE:TFX) by 75.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 135 shares of the medical technology company’s stock after purchasing an additional 58 shares during the quarter. Lindbrook Capital LLC’s holdings in Teleflex were worth $34,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Allworth Financial LP grew its position in Teleflex by 332.3% in the third quarter. Allworth Financial LP now owns 134 shares of the medical technology company’s stock valued at $26,000 after acquiring an additional 103 shares during the period. Venturi Wealth Management LLC bought a new stake in Teleflex in the third quarter valued at $27,000. Covestor Ltd grew its position in Teleflex by 305.6% in the third quarter. Covestor Ltd now owns 146 shares of the medical technology company’s stock valued at $29,000 after acquiring an additional 110 shares during the period. Massmutual Trust Co. FSB ADV grew its position in Teleflex by 418.5% in the fourth quarter. Massmutual Trust Co. FSB ADV now owns 140 shares of the medical technology company’s stock valued at $35,000 after acquiring an additional 113 shares during the period. Finally, ING Groep NV bought a new stake in Teleflex in the third quarter valued at $39,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Teleflex

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of the stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total value of $1,665,225.00. Following the transaction, the vice president now owns 10,050 shares of the company’s stock, valued at $2,261,250. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.43% of the company’s stock.

Teleflex Price Performance

Teleflex stock opened at $206.71 on Friday. The business’s 50-day simple moving average is $221.23 and its 200 day simple moving average is $225.61. The stock has a market cap of $9.74 billion, a price-to-earnings ratio of 27.45, a P/E/G ratio of 1.98 and a beta of 1.11. Teleflex Incorporated has a 12-month low of $177.63 and a 12-month high of $276.43. The company has a quick ratio of 1.29, a current ratio of 2.32 and a debt-to-equity ratio of 0.39.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.26 by $0.12. The business had revenue of $773.90 million for the quarter, compared to analysts’ expectations of $769.01 million. Teleflex had a return on equity of 14.98% and a net margin of 11.98%. The firm’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same quarter last year, the business earned $3.52 earnings per share. As a group, research analysts anticipate that Teleflex Incorporated will post 13.73 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.66%. The ex-dividend date was Thursday, February 29th. Teleflex’s payout ratio is 18.06%.

Wall Street Analyst Weigh In

TFX has been the topic of several research analyst reports. StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 23rd. Truist Financial decreased their target price on Teleflex from $270.00 to $265.00 and set a “hold” rating on the stock in a report on Friday, February 23rd. Royal Bank of Canada decreased their target price on Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a report on Friday, February 23rd. Finally, JMP Securities restated a “market outperform” rating and set a $285.00 target price on shares of Teleflex in a report on Friday, February 23rd. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, Teleflex currently has an average rating of “Moderate Buy” and a consensus target price of $267.50.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.